Hyperbaric oxygen therapy (HBOT) has garnered significant attention in the medical community for its benefits across various conditions. The United States FDA has recognized HBOT as an effective treatment for a range of medical conditions. These conditions, often referred to as “on-label” indications, are typically covered by insurance, thus making HBOT accessible to a broader population.

HBOT offers benefits for additional conditions not yet FDA-approved “off-label”. Extensive research supports its efficacy for many such conditions, making it widely utilized worldwide. It’s important to note that non-FDA-approved conditions are usually not covered by insurance and may not be available at hospital-based hyperbaric centers.

Covered Conditions

Also referred to as “on-label”, these conditions have been approved by the FDA for HBOT and are generally covered by insurance.

  • Air or Gas Embolism

  • Carbon Monoxide Poisoning

  • Central Retinal Artery Occlusion

  • Chronic Refractory Osteomyelitis

  • Crush Injury & Other Acute Traumatic Ischemia

  • Decompression Sickness (DCS, “Bends”)

  • Diabetic Lower Extremity Wounds

  • Failed Skin Grafts and Flaps

  • Gas Gangrene

  • Necrotizing Soft Tissue Infections

  • Non-Healing Wounds

  • Radiation Tissue Damage

  • Severe Acute Anemia

  • Sudden Sensorineural Hearing Loss

  • Thermal Burns

Non-Covered Conditions

Also referred to as “off-label”, these conditions are generally not covered by insurance.

  • Fibromyalgia

  • Multiple Sclerosis (MS)

  • Erectile Dysfunction

  • Crohn’s Disease

  • Sports Injury

  • Stroke

  • Post traumatic stress disorder (PTSD)

  • Concussion

  • Lyme Disease

  • Traumatic Brain Injury

  • Recovery from Plastic Surgery

  • Post-COVID-19 condition (Long COVID)

  • Migraine

  • Irritable Bowel Syndrome

  • Others not listed